BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 6420440)

  • 1. Evidence for dopaminergic stimulation of growth velocity in some hypopituitary children.
    Huseman CA; Hassing JM
    J Clin Endocrinol Metab; 1984 Mar; 58(3):419-25. PubMed ID: 6420440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth enhancement by dopaminergic therapy in children with intrauterine growth retardation.
    Huseman CA
    J Clin Endocrinol Metab; 1985 Sep; 61(3):514-9. PubMed ID: 3926809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous dopaminergic dysfunction: a novel form of human growth hormone deficiency and short stature.
    Huseman CA; Hassing JM; Sibilia MG
    J Clin Endocrinol Metab; 1986 Mar; 62(3):484-90. PubMed ID: 3080463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The growth hormone and somatomedin axis in short children with osteogenesis imperfecta.
    Marini JC; Bordenick S; Heavner G; Rose S; Hintz R; Rosenfeld R; Chrousos GP
    J Clin Endocrinol Metab; 1993 Jan; 76(1):251-6. PubMed ID: 8421094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum luteinizing hormone and follicle-stimulating hormone and the response to luteinizing hormone-releasing factor in children and adolescents with isolated growth hormone deficiency.
    Cohen HN; Kaplan SL; Grumbach MM
    J Clin Endocrinol Metab; 1983 Oct; 57(4):855-8. PubMed ID: 6411756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatomedin-C in normal puberty and in true precocious puberty before and after treatment with a potent luteinizing hormone-releasing hormone agonist.
    Harris DA; Van Vliet G; Egli CA; Grumbach MM; Kaplan SL; Styne DM; Vainsel M
    J Clin Endocrinol Metab; 1985 Jul; 61(1):152-9. PubMed ID: 3889035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LH and FSH responsiveness to intravenous gonadotropin-releasing hormone (GnRH) in children with hypothalamic or pituitary disorders: lack of effect of replacement therapy with human growth hormone.
    Kelch RP; Markovs M; Huss J
    J Clin Endocrinol Metab; 1976 Jun; 42(6):1104-13. PubMed ID: 777020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatomedin-C and growth in children with precocious puberty: a study of the effect of the level of growth hormone secretion.
    Rappaport R; Prevot C; Brauner R
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1112-7. PubMed ID: 3680478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of 1-year growth hormone (GH)-releasing hormone-(1-44) treatment on growth, somatomedin-C, and 24-hour GH secretion in six children with partial GH deficiency.
    Rochiccioli PE; Tauber MT; Coude FX; Arnone M; Morre M; Uboldi F; Barbeau C
    J Clin Endocrinol Metab; 1987 Aug; 65(2):268-74. PubMed ID: 3110202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of the somatomedin C/insulin-like growth factor I: response to exogenous growth hormone (GH) in GH-deficient children.
    Blethen SL; Daughaday WH; Weldon VV
    J Clin Endocrinol Metab; 1982 May; 54(5):986-90. PubMed ID: 7037825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preservation of dopaminergic and alpha-adrenergic function in children with growth hormone neurosecretory dysfunction.
    Bercu BB; Root AW; Shulman DI
    J Clin Endocrinol Metab; 1986 Oct; 63(4):968-73. PubMed ID: 3018032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone release in response to human pancreatic tumor growth hormone-releasing hormone-40 in children with short stature.
    Rogol AD; Blizzard RM; Johanson AJ; Furlanetto RW; Evans WS; Rivier J; Vale WW; Thorner MO
    J Clin Endocrinol Metab; 1984 Oct; 59(4):580-6. PubMed ID: 6434572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pubertal growth spurt in eight patients with true precocious puberty and growth hormone deficiency: evidence for a direct role of sex steroids.
    Attie KM; Ramirez NR; Conte FA; Kaplan SL; Grumbach MM
    J Clin Endocrinol Metab; 1990 Oct; 71(4):975-83. PubMed ID: 2401720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific, time-dependent actions of low-dose ethinyl estradiol administration on the episodic release of growth hormone, follicle-stimulating hormone, and luteinizing hormone in prepubertal girls with Turner's syndrome.
    Mauras N; Rogol AD; Veldhuis JD
    J Clin Endocrinol Metab; 1989 Nov; 69(5):1053-8. PubMed ID: 2507569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypogonadotropic hypogonadism in severe beta-thalassemia: effect of chelation and pulsatile gonadotropin-releasing hormone therapy.
    Wang C; Tso SC; Todd D
    J Clin Endocrinol Metab; 1989 Mar; 68(3):511-6. PubMed ID: 2493034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone (GH) responses to GH-releasing hormone during pubertal development in normal boys and girls: comparison to idiopathic short stature and GH deficiency.
    Gelato MC; Malozowski S; Caruso-Nicoletti M; Ross JL; Pescovitz OH; Rose S; Loriaux DL; Cassorla F; Merriam GR
    J Clin Endocrinol Metab; 1986 Jul; 63(1):174-9. PubMed ID: 3086356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in serum immunoreactive and bioactive growth hormone concentrations in boys with advancing puberty and in response to a 20-hour estradiol infusion.
    Cemeroglu AP; Barkan AL; Kletter GB; Beitins IZ; Foster CM
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2166-71. PubMed ID: 9215289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness.
    van den Berghe G; Weekers F; Baxter RC; Wouters P; Iranmanesh A; Bouillon R; Veldhuis JD
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3217-26. PubMed ID: 11443192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone.
    Pasquino AM; Pucarelli I; Roggini M; Segni M
    J Clin Endocrinol Metab; 2000 Feb; 85(2):619-22. PubMed ID: 10690865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate).
    Juul A; Scheike T; Nielsen CT; Krabbe S; Müller J; Skakkebaek NE
    J Clin Endocrinol Metab; 1995 Oct; 80(10):3059-67. PubMed ID: 7559897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.